Status of common sexually transmitted infection in population referred for colposcopy and correlation with human papillomavirus infection

Table 2 Comparison of positive rates of detected STI pathogens among different histopathological results

STIs	Total /N	≤LSIL N = 593	≥HSIL N = 126	Х²	P
C. trachomatis	86	77 (13.0%)	9 (7.1%)	3.368	0.041
U. urealyticum	104	81 (13.7%)	23 (18.3%)	1.733	0.118
M. hominis	43	34 (5.7%)	9 (7.1%)	0.3674	0.536
M. genitalium	9	7 (1.2%)	2 (1.6%)	0.139	0.487
U. parvum serovar 1	60	47 (7.9%)	13 (10.3%)	0.777	0.577
U. parvum serovar 3	129	110 (18.5%)	19 (15.1%)	0.850	0.443
U. parvum serovar 6	145	113 (19.1%)	32 (25.4%)	2.595	0.113
U. parvum serovar 14	6	4 (0.7%)	2 (1.6%)	1.046	0.284
N. gonorrhoeae	8	8 (1.3%)	0 (0.0%)	1.719	0.363
HSV-2	36	32 (5.4%)	4 (3.2%)	1.078	0.374
Single infection	316	264 (44.5%)	52 (41.3%)	1.089	0.580
Multiple infection	142	113 (19.1%)	29 (23.0%)	1.089	0.580

Multiple infections double counting
LSIL, low-grade squamous intraepithelial lesion; HSIL, high-grade squamous intraepithelial lesion; STIs, sexually transmitted infections; C. trachomatis, Chlamydia Trachomatis; U. urealyticum, Ureaplasma urealyticum; M. hominis, Mycoplasma hominis; M. genitalium, Mycoplasma genitalium; U. parvum, Ureaplasma parvum; N. gonorrhoeae, Neisseria Gonorrhoeae; HSV-2, herpes simplex virus 2

ISSN: 1472-6874